| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |